VIDEO: Meeting to address undertreatment of CVD in patients with psoriatic disease

Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania, discusses an upcoming program from the National Heart, Lung, and Blood Institute.

The meeting will discuss the undertreatment of traditional cardiovascular risk factors in people with psoriatic disease, focusing in particular on the use of statins.

The meeting will be held April 9. Register for this free event by clicking here.